Lupin Signs Patent License for Gastrointestinal Drug in India
September 18, 2024 14:01
Lupin has entered into a patent license agreement with Takeda to commercialise Vonoprazan tablets, a novel gastrointestinal drug, in the Indian market. The drug will be marketed under the brand...